GLP-1 Coverage Cost-Benefit Analysis
Over the past several years, glucagon-like peptide-1 (GLP-1) medications—such as Wegovy and Zepbound—have reshaped metabolic care. These drugs were originally
Over the past several years, glucagon-like peptide-1 (GLP-1) medications—such as Wegovy and Zepbound—have reshaped metabolic care. These drugs were originally
In 2026, the employee benefits market is being shaped by a variety of trends, including regulatory volatility, shifting compliance priorities,
Cost management and affordability become top priorities as employers brace for another year of significant healthcare cost increases in 2026.
Flexible spending accounts (FSAs) have existed since the 1970s and are designed to help employees pay for qualified out-of-pocket expenses
Established in 2003, health savings accounts (HSAs) offer individuals a tax-friendly way to set aside money for medical expenses. They
Parrott Benefit Group understands the challenges today’s employers face. From rising health care costs and confusing compliance changes, to concerns